Finding the molecular switches behind new infectious diseases

Google DeepMind Blog News

Summary

Professor Clare Bryant at the University of Cambridge is using DeepMind's Co-Scientist to rapidly identify molecular switches that cause severe diseases like sepsis when pathogens jump between species, cutting research time from years to months.

Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Original Article
View Cached Full Text

Cached at: 05/19/26, 07:15 PM

# Finding the molecular switches behind new infectious diseases Source: [https://deepmind.google/blog/finding-the-molecular-switches-behind-new-infectious-diseases/](https://deepmind.google/blog/finding-the-molecular-switches-behind-new-infectious-diseases/) The majority of emerging infectious diseases are caused by pathogens that jump from animals to humans, such as Ebola, HIV, flu and Covid\-19\. Professor Clare Bryant at the University of Cambridge is using Co\-Scientist to hunt for the molecular switches that cause severe diseases, like sepsis, in humans when pathogens leap between species, and find new approaches to prevent this happening\. Testing Co\-Scientist, Bryant fed it a summary of one of her grant proposals studying flu in birds and humans outlining her lab’s research questions\. The tool generated and ranked a set of promising hypotheses — some she'd already considered, some she hadn't\. The unfamiliar ones were the most thought\-provoking\. When the grant was funded, Bryant fed in the full, detailed proposal\. Later, reading through the output on a train to Brussels, she had an "a\-ha\!" moment: Co\-Scientist had prioritised a protein that hadn’t been on her radar, connected to several signalling pathways she was already interested in\. She spent the rest of the week itching to give it more data\. Back at her lab, she added unpublished material, kept confidential within Co\-Scientist\. With each back\-and\-forth, the hypotheses sharpened, moving from candidate proteins down to the specific amino acids her lab could focus its experiments on\. Bryant's team is now building cell lines containing the amino acid mutations to test the refined hypotheses\. To get to the point of identifying precise amino acids would normally have taken two to three years of experimental work\. But her lab is now on track to complete it in six months, she says, if the work with Co\-Scientist has led them to the right targets\.

Similar Articles

Uniting biological toolkits for a new approach to ALS

Google DeepMind Blog

DeepMind's Co-Scientist AI tool bridges the expertise of two researchers from different biological fields to accelerate ALS research by generating testable hypotheses and identifying RNA-based mechanisms for potential therapies.

Accelerating discovery of liver disease mechanisms

Google DeepMind Blog

DeepMind's Co-Scientist AI system helped researchers at the University of Edinburgh generate a novel, experimentally verified hypothesis linking the NLRP3 inflammasome to the mechanism of drug resmetirom in MASH liver disease, potentially enabling targeted combination therapies.

Opening new paths in aging research

Google DeepMind Blog

Calico Life Sciences uses Google DeepMind's Co‑Scientist to connect scattered findings in aging biology and generate testable hypotheses, such as a novel hypothesis about ISR regulation by metabolism.

Fast-tracking genetic leads to reverse cellular aging

Google DeepMind Blog

DeepMind's Co-Scientist is helping biologists identify genetic factors that reverse cellular aging by mining literature and analyzing screening data, reducing analysis time from months to days.